Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group-Reference-Cited by-同舟云学术

Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group

Published:2017-01 Issue:1 Volume:47 Page:35-49
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Intern Med J

Author:

Talaulikar Dipti¹²³,Tam Constantine S.⁴⁵⁶,Joshua Douglas³⁷⁸,Ho Joy Phoebe³⁷⁸,Szer Jeff³⁶⁹,Quach Hang³⁵⁶,Spencer Andrew³⁶¹⁰,Harrison Simon³⁴⁶,Mollee Peter³¹¹¹²,Roberts Andrew W.³⁶⁹¹³,Horvath Noemi³¹⁴,Lee Cindy³¹⁴,Zannettino Andrew³¹⁵,Brown Ross³⁷,Augustson Bradley³¹⁶,Jaksic Wilfrid³¹⁷,Gibson John³⁷⁸,Kalff Anna³¹⁰,Johnston Anna³¹⁸¹⁹,Trotman Judith²⁰,Kalro Akash³²¹,Grigoriadis George²²²³,Ward Chris³⁸²⁴,Prince H. Miles³⁴⁶

Affiliation:

1. Department of Haematology; Canberra Hospital; Canberra Australian Capital Territory Australia

2. Australian National University; Canberra Australian Capital Territory Australia

3. Medical and Scientific Advisory Group; Myeloma Australia; Melbourne Victoria Australia

4. Department of Haematology; Peter MacCallum Cancer Centre; Melbourne Victoria Australia

5. Department of Haematology; St Vincent's Hospital; Melbourne Victoria Australia

6. Faculty of Medicine, Dentistry and Health Sciences; The University of Melbourne; Melbourne Victoria Australia

7. Department of Haematology; Royal Prince Alfred Hospital; Sydney New South Wales Australia

8. Sydney Medical School; University of Sydney; Sydney New South Wales Australia

9. Department of Clinical Haematology and BMT; Royal Melbourne Hospital; Melbourne Victoria Australia

10. Department of Haematology; The Alfred Hospital; Melbourne Victoria Australia

11. Department of Haematology; Princess Alexandra Hospital; Brisbane Queensland Australia

12. School of Medicine; University of Queensland; Brisbane Queensland Australia

13. Walter and Eliza Hall Institute of Medical Research; Melbourne Victoria Australia

14. Department of Haematology; Royal Adelaide Hospital; Adelaide South Australia Australia

15. Faculty of Medical Sciences; University of Adelaide; Adelaide South Australia Australia

16. Department of Haematology; Sir Charles Gairdner Hospital; Perth Western Australia Australia

17. Department of Haematology; Queen Elizabeth Hospital; Adelaide South Australia Australia

18. Department of Haematology; Royal Hobart Hospital; Hobart Tasmania Australia

19. Faculty of Health; University of Tasmania; Hobart Tasmania Australia

20. Department of Haematology; Concord Hospital; Sydney New South Wales Australia

21. Department of Haematology; Royal Darwin Hospital; Darwin Northern Territory Australia

22. Department of Haematology; Southern Health; Melbourne Victoria Australia

23. Faculty of Medicine, Nursing and Health Sciences; Monash University; Melbourne Victoria Australia

24. Department of Haematology; Royal North Shore Hospital; Sydney New South Wales Australia

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/imj.13311/fullpdf

Reference87 articles.

1. The 2016 revision of the World Health Organization classification of lymphoid neoplasms;Swerdlow;Blood,2016

2. Waldenstrom macroglobulinemia: a surveillance, epidemiology, and end results database review from 1988 to 2005;Sekhar;Leuk Lymphoma,2012

3. MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia;Treon;N Engl J Med,2012

4. Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial;Rummel;Lancet,2013

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of patients with Waldenström macroglobulinaemia: clinical practice update from the Myeloma Foundation of Australia Medical and Scientific Advisory Group;Internal Medicine Journal;2023-04

2. Bleeding Propensity in Waldenström Macroglobulinemia: Potential Causes and Evaluation;Thrombosis and Haemostasis;2022-07-11

3. Bleeding in the Setting of Lymphoma, with a Focus on Waldenström Macroglobulinaemia;Interdisciplinary Cancer Research;2022

4. A practical guide to laboratory investigations at diagnosis and follow up in Waldenström macroglobulinaemia: recommendations from the Medical and Scientific Advisory Group, Myeloma Australia, the Pathology Sub-committee of the Lymphoma and Related Diseases Registry and the Australasian Association of Clinical Biochemists Monoclonal Gammopathy Working Group;Pathology;2020-02

5. Asymptomatic Waldenström Macroglobulinemia: Should We Consider a Different Terminology?;Journal of Clinical Oncology;2019-10-10